Breathe Well Live Well
|
Sanofi/Regeneron asthma drug successful in Phase 2 trial
Seeking Alpha (registration) The three highest doses of dupilumab in combination with standard-of-care therapy met the primary endpoint of a statistically significant improvement from baseline in forced expiratory volume over one second (FEV1) at week 12 in patients with high … |
View full post on asthma – Google News
|
Clearing The Air On The Sanofi-Regeneron Asthma Drug Trial
Seeking Alpha Results announced this week of a clinical trial testing the drug dupilumab, made by the biotechnology company Regeneron Pharmaceuticals (REGN) and global pharmaceutical company Sanofi (SNY) gave hope to asthma sufferers and got the attention of … |
View full post on asthma – Google News